Partner Content Partner Content Four Key Reasons to Attend SMi's 2019 Biosimilars Conference Four Key Reasons to Attend SMi's 2019 Biosimilars
Partner Content Partner Content 10 Key Reasons to attend SMi’s 10th Annual Biosimilars Confe... 10 Key Reasons to attend Biosimilars
Partner Content Partner Content Michel Mikhail invites Biosimilar experts to attend SMi’s 10... Michel Mikhail invites Biosimilar experts to attend SMi
Events Partner Content SMi’s 10th Annual Biosimilars Conference Biosimilars Conference, London, Sept 2019
Partner Content Partner Content Save the date for SMi’s 10th Annual Biosimilars Conference 2... Save the date for SMi’s 10th Annual Biosimilars Conf
Partner Content Partner Content SMi’s release speaker interview Anita Burrell, speaker at Bi... Biosimilars USA conference information
News EnteroBiotix cues up larger trial of microbiome IBS therapy EnteroBiotix has reported phase 2a proof-of-concept data for its therapy for irritable bowel syndrome (IBS) based on gut microbiome species.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
